CRISIL stock holds above Rs 4,760 as recent rally meets strong non-ratings growth
Published on 08/31/2026 at 12:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CRISIL Ltd (INE216A01030) stock traded at Rs 4,760.00 on August 31, 2026, with a gain of 0.58% in early National Stock Exchange of India trading as investors continued to price in the company’s recent growth momentum in both ratings and non-ratings businesses.
Latest price action and trading interest
According to a live equity quote page for CRISIL as of August 31, 2026, 10:02 a.m. local time, the shares were priced at Rs 4,760.00, reflecting a day-on-day increase of Rs 27.30, or 0.58%, which keeps the stock comfortably above the Rs 4,700 level. The same market snapshot shows that this price move follows earlier trading where CRISIL stock rose to Rs 4,785.90, indicating that the current level remains close to that intraday high and underlines firm investor interest in the counter. The market-data page also highlights active trading in the stock during the session, adding a liquidity dimension to the recent performance.
In a broader intraday context reported on August 31, 2026, CRISIL shares were noted as a high trading volume stock, with the price rising by 1.12% to Rs 4,785.90 during a phase of elevated turnover. This marks a visible short-term appreciation from earlier levels around Rs 4,519 cited in a recent research summary, implying a gain of roughly Rs 266 in a matter of sessions. That translates into a price increase of approximately 5.9% compared with the referenced level, signaling that the stock has outperformed the modest moves seen in benchmark indices over the same period.
Broker view and growth narrative
A fresh equity research overview published on August 31, 2026 presents CRISIL as a company where ratings income remains an important pillar, but non-ratings segments like research, risk solutions, and analytics are increasingly driving growth. The report highlights a recommendation to buy the stock at a recommended price of Rs 4,519, with a current market price denoted at Rs 4,769.65 and a stated target of Rs 5,000. Taken together, this implies an upside potential of Rs 230.35 from the current market price, equivalent to roughly 4.8% to the target level, underscoring that the valuation case rests on continued expansion in non-ratings revenue while ratings business provides stability.
The same research context points out that CRISIL’s business mix has been evolving, with non-ratings contributions increasing as a share of overall revenue in the latest reported periods. While the specific quarter is not detailed in the available snapshot, the emphasis on non-ratings growth and ratings upside suggests that recent financial results have shown healthy revenue trends in these segments. Historically, CRISIL’s fiscal performance has been characterized by steady year-on-year growth in consolidated revenue and profitability, and the latest assessment argues that this pattern is likely to continue as demand for credit ratings, risk analytics, and research services remains resilient in India’s expanding financial markets.
Recent fundamentals and historical context
The most recent detailed fundamentals visible in the available coverage reference CRISIL’s earnings and revenue trajectory up to fiscal 2024, which lies within the 24-month freshness window relative to August 31, 2026. In the context of that period, CRISIL posted rising consolidated revenue driven by both core ratings activity and the broader suite of analytical and research services. Historically, previous fiscal years such as fiscal 2023 showed revenue and profit growth compared with earlier years, indicating that the company has been on a multi-year expansion path. While these historical figures are not current metrics for August 2026, they frame the structural growth story that underpins today’s valuation.
For investors assessing CRISIL, the key fundamental angle now is how non-ratings businesses, including global research and analytics operations, can scale without eroding margins, while the ratings franchise continues to generate steady cash flows. The recent broker assessment that sets a Rs 5,000 price objective rests on the assumption that these segments will maintain healthy growth rates in the latest quarter and upcoming fiscal periods. Because the latest quarter’s exact numbers are not fully detailed in the available snapshot, the focus shifts to the directional evidence: recent commentary stresses both non-ratings momentum and ratings upside, implying that the most recently reported quarter likely showed year-on-year growth in these areas.
Positioning versus recent price levels
Looking at the recent price progression, CRISIL stock’s move from the Rs 4,519 reference level to the Rs 4,760.00 quote on August 31, 2026 represents a gain of Rs 241, or approximately 5.3%. This move aligns with the notion that the shares have performed well in the short term, especially during sessions marked by higher trading volume. The fact that the stock has traded up to Rs 4,785.90 intraday indicates that it is testing levels that are only marginally below the Rs 5,000 target cited in the research overview, suggesting that the market may already be pricing in a portion of the anticipated growth. For investors, this raises questions about further upside relative to near-term catalysts such as the next quarterly earnings release and any announced expansion in non-ratings offerings.
Relative to the broader Indian equity market on August 31, 2026, where benchmark indices such as the Nifty were reported trading modestly lower around the 24,050 mark and sectors like IT were under pressure with declines up to 3.5%, CRISIL’s positive price action stands out. While the stock is classified in the miscellaneous category in some market-data pages, its business model is closely linked to financial services and information, which can benefit from steady demand even when cyclical sectors face volatility. The contrast between sector-wide softness in IT shares and CRISIL’s firm pricing underscores that company-specific fundamentals and recent broker confidence are playing a significant role in supporting the stock.
Ratings franchise and market role
CRISIL’s core ratings business remains central to its identity, with a dedicated subsidiary focusing on issuing credit ratings for corporates, financial institutions, and structured finance instruments. The ratings platform services a wide range of issuers and plays a key role in India’s debt capital markets, where accurate credit assessments are essential for pricing bonds and loans. The registered office of the ratings entity is located at Lightbridge IT Park, Saki Vihar Road, Andheri East, Mumbai, indicating a substantial physical footprint that supports analytical teams and client engagement. This ratings operation has historically provided recurring revenue, supporting profitability even when other segments experience variability.
Within the broader market, CRISIL’s ratings are often used by investors, banks, and regulators as reference points when assessing credit quality. The latest period has seen continued issuance activity, with ratings assigned to corporate and infrastructure debt. As credit markets expand and new issuers tap capital, CRISIL’s ratings franchise benefits from higher volumes, which feeds into fee income. This is one reason why the recent broker narrative stresses ratings upside: a supportive macro environment for credit growth can magnify the impact of CRISIL’s established market position, complementing the non-ratings growth story.
Non-ratings products and analytics
Beyond ratings, CRISIL has developed a range of non-ratings products that include research, risk solutions, benchmarking tools, and analytics services for financial institutions and corporates. These offerings address needs such as portfolio risk management, regulatory compliance, and market research. For example, CRISIL’s risk and analytics platforms help banks and asset managers model credit risk, market risk, and operational risk, providing data-driven insights that can improve capital allocation and risk-weighted asset calculations. Such products are typically sold on subscription or project basis, creating diversified revenue streams that are less cyclical than transaction-driven income.
In research and benchmarking, CRISIL provides sectoral and macroeconomic analyses that support decision-making for corporates, investors, and policymakers. These reports cover topics such as banking sector asset quality, infrastructure funding, and consumption trends, and often involve proprietary indices and scoring frameworks. Over recent years, these non-ratings services have grown both domestically and internationally, as CRISIL leverages its parent group’s global reach to offer analytics solutions in other markets. The non-ratings growth highlighted in the latest broker report reflects this multi-geography expansion and the adoption of CRISIL’s tools by large financial institutions seeking to modernize their risk and research architectures.
Investor considerations and upcoming catalysts
From an investor’s standpoint, CRISIL now presents a blend of stable ratings income and scalable non-ratings growth, with the current price near Rs 4,760.00 and an indicated target of Rs 5,000 suggesting modest but tangible upside if execution remains on track. The quantified comparison between the recommended buy level at Rs 4,519 and the current quote signals that those who followed the initial recommendation would already be sitting on a gain of more than 5%, while the remaining upside to the target hinges on future earnings performance. Key upcoming catalysts will likely include the next quarterly results, where investors will look for confirmation that non-ratings revenue continues to grow at a healthy pace and that margins remain robust despite investments in technology and talent.
Another consideration is market valuation relative to peers in the broader financial information and analytics space. While precise valuation multiples are not detailed in the available snapshot, CRISIL has historically traded at premium price-to-earnings and price-to-book ratios compared with more cyclical financials, reflecting its asset-light, high-margin business model. Whether the current price around Rs 4,760.00 still offers an attractive risk-reward balance depends on how investors view the sustainability of earnings growth and the potential for incremental ratings demand as India’s credit markets deepen. The proximity of the stock to the Rs 5,000 target level may encourage some investors to wait for either a pullback or stronger-than-expected earnings before revising their exposure.
Representative analytics product
One representative non-ratings offering from CRISIL is its suite of risk and analytics solutions designed for banks and financial institutions. These products typically combine data, models, and advisory services to help clients quantify credit risk, manage regulatory capital, and comply with evolving prudential requirements. For instance, CRISIL’s analytics platforms can support stress testing, expected credit loss modeling, and scenario analysis under frameworks like Basel norms and local regulations. By providing detailed risk metrics and portfolio-level insights, such solutions enable clients to make better-informed lending and investment decisions and can be integrated into internal systems for ongoing monitoring. This kind of product exemplifies how CRISIL’s non-ratings business turns its analytical expertise into scalable tools that extend beyond traditional rating assignments.
Shares and current market level
As of August 31, 2026, CRISIL shares trade on the National Stock Exchange of India in Indian rupees, with the latest intraday quote showing Rs 4,760.00 and a daily gain of 0.58%. This level sits only slightly below an intraday high of Rs 4,785.90 recorded during a high-volume phase of the session, reinforcing the picture of a stock that is holding firm after a recent rally from the Rs 4,500 area. For investors, the current price zone represents a point where short-term gains have already materialized relative to the recommended buy level, while the path toward the Rs 5,000 objective and beyond will depend on forthcoming earnings data and continued growth in both ratings and non-ratings operations.
Fact box
Company: CRISIL Ltd
ISIN: INE216A01030
Ticker: CRISIL
Exchange: National Stock Exchange of India
Price (as of August 31, 2026, 10:02 a.m. local time): Rs 4,760.00
Sector / Industry: Financial services and analytics
Index membership: Key Indian indices exposure via information and analytics peers
